跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

安全信息

32422

Supelco

头孢噻呋 盐酸盐

VETRANAL®, analytical standard

别名:

(6R,7R)-7-{[(2Z)-2-(2-氨基-4-噻唑基)-2-(甲氧亚氨基)乙酰基]氨基}-3-{[(2-呋喃甲酰基)硫代]甲基}-8-氧-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸 盐酸盐, 3-[(2-呋喃羰基)硫代]甲基]-7-[2-(2-氨基-4-噻唑基)-2-(甲氧基亚氨基乙酰胺基)-3-头孢烯-4-羧酸 盐酸盐

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C19H17N5O7S3 · HCl
CAS号:
103980-44-5
分子量:
560.02
MDL编号:
MFCD04038020
UNSPSC代码:
41116107
PubChem化学物质编号:
329754200
NACRES:
NA.24

等级

analytical standard

质量水平

100

产品线

VETRANAL®

保质期

limited shelf life, expiry date on the label

技术

HPLC: suitable
gas chromatography (GC): suitable

应用

forensics and toxicology
pharmaceutical (small molecule)

包装形式

neat

SMILES字符串

Cl.CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSC(=O)c3ccco3)=C(N2C1=O)C(O)=O)c4csc(N)n4

InChI

1S/C19H17N5O7S3.ClH/c1-30-23-11(9-7-34-19(20)21-9)14(25)22-12-15(26)24-13(17(27)28)8(5-32-16(12)24)6-33-18(29)10-3-2-4-31-10;/h2-4,7,12,16H,5-6H2,1H3,(H2,20,21)(H,22,25)(H,27,28);1H/b23-11-;/t12-,16-;/m1./s1

InChI key

KEQFDTJEEQKVLM-JUODUXDSSA-N

正在寻找类似产品? 访问 产品对比指南

应用

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

推荐产品

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

法律信息

VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

储存分类代码

11 - Combustible Solids

WGK

WGK 3

法规信息

监管及禁止进口产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
BCCL2502
BCCH1294
BCCB8697
BCBZ8753
BCBS3479V

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

C L McLaughlin et al.
Journal of dairy science, 95(8), 4363-4371 (2012-07-24)
The objectives of this study were to evaluate efficacy of a 2-dose regimen of ceftiofur crystalline free acid sterile suspension (CCFA-SS) for treatment of acute metritis in lactating dairy cows under field conditions and to provide additional safety and injection
S M Rowe et al.
Journal of dairy science, 103(7), 6473-6492 (2020-05-26)
Selective dry-cow therapy (SDCT) could be used to reduce antibiotic use on commercial dairy farms in the United States but is not yet widely adopted, possibly due to concerns about the potential for negative effects on cow health. The objective
Victoriya V Volkova et al.
PloS one, 7(5), e36738-e36738 (2012-05-23)
Antimicrobial use in food animals may contribute to antimicrobial resistance in bacteria of animals and humans. Commensal bacteria of animal intestine may serve as a reservoir of resistance-genes. To understand the dynamics of plasmid-mediated resistance to cephalosporin ceftiofur in enteric
C L McLaughlin et al.
Theriogenology, 79(4), 725-734 (2013-01-08)
Two studies were conducted to determine if clinical metritis could be prevented or decreased in at-risk lactating dairy cows by a single treatment with Excede Sterile Suspension (ceftiofur crystalline free acid sterile suspension [CCFA-SS]) administered within 24 hours after an
Dixie F Mollenkopf et al.
Applied and environmental microbiology, 78(13), 4552-4560 (2012-05-01)
bla(CTX-M) beta-lactamases confer resistance to critically important cephalosporin drugs. Recovered from both hospital- and community-acquired infections, bla(CTX-M) was first reported in U.S. livestock in 2010. It has been hypothesized that veterinary use of cephalosporins in livestock populations may lead to
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门